logo inner

Medical Director (Remote)

4D Molecular TherapeuticsUnited StatesRemote
This job is no longer open

Attention recruitment agencies:


All agency inquiries are vetted through 4DMT’s internal Talent Acquisition team. No unsolicited resumes will be accepted. The 4DMT Talent Acquisition team must expressly engage agencies on any requisition. Agencies contacting hiring managers directly will not be tolerated, and doing so may impact your ability to work with 4DMT in the future.4DMT is a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines. We seek to unlock the full potential of gene therapy using our platform, Therapeutic Vector Evolution (TVE), which combines the power of directed evolution with our approximately one billion synthetic AAV capsid-derived sequences to invent evolved vectors for use in our products.

We believe key features of our targeted and evolved vectors will help us create targeted product candidates with improved therapeutic profiles. These profiles will allow us to treat a broad range of large market diseases, unlike most current genetic medicines that generally focus on rare or small market diseases.  Company Differentiators: •    Fully integrated clinical-phase company with internal manufacturing•    Demonstrated ability to move rapidly from idea to IND•    Five candidate products in the clinic and two declared pre-clinical programs•    Robust technology and IP foundation, including our TVE and manufacturing platforms•    Initial product safety and efficacy data substantiates the value of our platforms•    Opportunities to expand to other indications and modalities within genetic medicineGENERAL SUMMARY:Reporting to the Therapeutic Area Head-Ophthalmology, the Medical Director is accountable for the design, execution, and analysis of clinical trials in the Ophthalmology Therapeutic Area. RESPONSIBILITIES:

  • Provides clinical leadership to multidisciplinary study execution teams drawn from clinical operations, clinical science, biometrics, regulatory affairs, CMC, pharm/tox, drug safety, commercial, and alliance partners
  • Has lead accountability on the study teams for delivery of study protocols, study conduct, and study readouts
  • Serves as medical monitor on clinical studies.
  • Organizes and leads scientific advisory board meetings. Interacts with external experts and stakeholders to gather input. 
  • Serves as the primary clinical author of development plans, study protocols, amendments, ICFs,  IBs, INDs, annual reports, CSRs, regulatory submissions / correspondence, and project-related documents. Accountable for the accuracy of all medical content of such documents.
  • Works with the research organization and the portfolio management team to identify and support new project opportunities.
  • Collaborates to identify program risks, and to create and implement mitigation strategies
  • Other duties as assigned

QUALIFICATIONS:Education:

  • Medical Degree (M.D.)
  • Residency training in Ophthalmology
  • Board certification a plus

Experience:

  • 3+ years of clinical ophthalmology research in the biopharmaceutical industry
  • Experience with retina clinical trials
  • Experience with gene therapy a plus
  • Experience in other phases (Phase 1, 2, 4) of clinical research a plus.

Skills:

  • Experience writing clinical research protocols and acting as a medical monitor
  • Experience in data analysis, data interpretation, and medical writing
  • Effective written and verbal communication skills, including public speaking
  • Knowledge of ICH-GCP and FDA regulatory guidelines.
  • Knowledge of international regulatory guidelines a plus.

Other:

  • Ability to travel 15% (3 days/month)
  • Remote/hybrid acceptable but Local/Hybrid preferred

Compensation range: $268,000k/yr - $345,000k/yrPlease note, the base salary compensation range and actual salary offered to the final candidate depends on various factors: relevant work experience, skills, and years of experience4DMT provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, national origin, age, disability, genetic information, marital status, status as a covered veteran, and any other category protected under applicable federal, state, provincial and local laws.Equal Opportunity Employer/Protected Veterans/Individuals with Disabilities

This job is no longer open

Life at 4D Molecular Therapeutics

The mission of 4D Molecular Therapeutics is to design and develop transformative gene therapy products using our proprietary technology to create novel adeno-associated virus variants to be utilized as treatments for serious unmet medical conditions. Our products are unlocking the full potential of gene therapy to treat, and potentially cure, genetic diseases. A large number of patients and diseases, who previously were not treatable by gene therapy, will be addressable by 4D products. 4D has one of the deepest and most diverse product pipelines in the gene therapy field. Adeno-associated virus (AAV) vectors have emerged as a favored delivery vehicle for gene therapy in the human body. They can deliver the genes for therapeutic proteins to accessible tissues in the body and are generally considered safe. Several AAV gene therapy products are in late-stage clinical development, and one product is approved in the EU (Glybera, Uniqure). However, these first-generation AAV vectors have limited utility for the majority of diseases. Many of these common AAV were discovered as laboratory contaminants and monkey infections, for example; they have not been customized as targeted medicines. In contrast, 4D customized AAV vectors, and the products made from them, are designed to unlock the full potential of gene therapy. Through 4D's Therapeutic Vector Evolution, we are able to create customized vectors solutions to overcome the hurdles identified with first-generation AAV vectors. 4D is creating the ultimate gene therapy products to cure genetic diseases using new customized delivery vehicles (vectors) to shuttle genes into the cells in any organ in the body. This 4D library of vectors will soon include several for the liver, several for the brain, several for the heart, the eye, muscle, and so on. Doctors will be able to hand pick a vector for any patient based on the organ that is diseased.
Thrive Here & What We Value1. Collaborative and innovative work environment2. Emphasis on scientific excellence and innovation3. Focus on patient outcomes and improving lives through genetic medicine4. Opportunities for career growth and professional development5. Commitment to diversity, equity, and inclusion6. Robust technology and IP foundation, including TVE and manufacturing platforms7. Initial product safety and efficacy data substantiates platform value8. Rapid progression from idea to IND9. Expanding opportunities in genetic medicine indications and modalities10. Internal manufacturing capabilities
Your tracker settings

We use cookies and similar methods to recognize visitors and remember their preferences. We also use them to measure ad campaign effectiveness, target ads and analyze site traffic. To learn more about these methods, including how to disable them, view our Cookie Policy or Privacy Policy.

By tapping `Accept`, you consent to the use of these methods by us and third parties. You can always change your tracker preferences by visiting our Cookie Policy.

logo innerThatStartupJob
Discover the best startup and their job positions, all in one place.
Copyright © 2024